Many of the world's most important advances in medical technology were developed in Yokneam.
Rewalk's Exoskeleton enables individuals with spinal cord injury (SCI) that would otherwise be confined to a wheelchair or worse, to stand upright and walk again. The rehabilitation robot market that Rewalk pioneered in is expected to grow dramatically from $43.3 million to $1.8 billion annually by 2020.
Disposable camera capsules developed in Yokneam by Given Imaging have already spared more than 1.5 million people from having to undergo invasive endoscopic procedures. Patients simply swallow a disposable pill-sized camera that enables their physician to visualize the small bowel, esophagus and colon to monitor and diagnose disorders of the gastrointestinal tract. With over 100 million people diagnosed each year, gastrointestinal (GI) disorders are one of the most common complaints made to physicians worldwide and the gastrointestinal endoscopy devices market is expected to reach $6.6 billion in 2017 and $11 billion in 2023.
Treatments for Glaucoma, Alzheimer's and Parkinson disease are only a few of the research projects currently underway in the Abital Pharma Pipelines incubator located in Yokneam.
Quality of life and development of medical devices go hand in hand.
Changing the way medical conditions are diagnosed...
Robotic systems and surgical tools for minimally invasive surgery.